Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

Source:http://linkedlifedata.com/resource/pubmed/id/3034423

Download in:

View as

General Info

PMID
3034423